Document:

EX-10.77

 Exhibit 10.77 
 SIXTH AMENDMENT TO 
 NOTE AND WARRANT PURCHASE AGREEMENT 

This Sixth Amendment to Note and Warrant Purchase Agreement (this “Sixth Amendment”) is dated as of May 7, 2012,
and amends that certain Note And Warrant Purchase Agreement dated February 21, 2008, as amended by that certain First Amendment to Note and Warrant Purchase Agreement, made effective as of December 29, 2008, and that certain Second
Amendment to Note and Warrant Purchase Agreement, dated as of October 9, 2009, that certain Third Amendment to Note and Warrant Purchase Agreement, dated as of November 10, 2010, that certain Fourth Amendment to Note and Warrant Purchase
Agreement, dated as of March 30, 2012, and that certain Fifth Amendment to Note and Warrant Purchase Agreement, dated as of May 1, 2012 (as so amended, the “Existing Agreement”) by and among Stereotaxis, Inc., a Delaware
corporation (the “Company”), Sanderling Venture Partners VI Co-Investment Fund, L.P., Sanderling VI Beteiligungs GmbH & Co KG, Sanderling VI Limited Partnership and Alafi Capital Company LLC (each, a
“Lender” and together, the “Lenders”). 
 RECITALS 

WHEREAS, the Lenders and the Company are parties to the Existing Agreement, pursuant to which the Lenders have extended a $10
million borrowing facility to the Company, the Committed Funds from each Lender on a several (but not joint and several) basis; 

WHEREAS, the Company and the Lenders desire to further amend the Existing Agreement, as set forth more specifically in this Sixth
Amendment. 
 NOW, THEREFORE, in consideration of the foregoing recitals and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Parties agree as follows: 

ARTICLE 1 
 DEFINITIONS 
 1.1 Defined Terms. As used in this Sixth Amendment, the
following terms shall have the meanings set forth below: 
 1.1.1 “2013 Extension Exercise Price” means the
Closing Bid Price on the Trading Day immediately prior to the date of this Sixth Amendment (or on the date of this Sixth Amendment if executed and delivered after 4:00 p.m. Eastern Time on the date hereof). 

1.1.2 “Qualified Financing” (in lieu of and replacing the definition previously set forth in the Existing Agreement)
shall mean additional financing from any third party (other than indebtedness of the Company to banks, commercial finance lenders and similar financial institutions) received by the Company after the date of this Sixth Amendment in the aggregate
amount of not less than Thirty Million Dollars ($30,000,000). 

 1.2 Undefined Terms. Terms and definitions used in this Sixth Amendment but not defined in this
Section 1 shall have the same meanings given to such terms in the Existing Agreement. 
 ARTICLE 2 

CERTAIN AMENDMENTS 
 2.1
Extension to March 31, 2013. Notwithstanding anything to the contrary in the Existing Agreement, the Commitment Period under Section 1.2 and the Maturity Date under Section 1.4 is hereby extended to the earlier of
(i) March 31, 2013, and (ii) the date on which the Company consummates a Qualified Financing. Each reference to “May 15, 2012” set forth in Sections 1.2 and 1.4 of the Existing Agreement (as amended by the First, Second,
Third, Fourth, and Fifth Amendment thereto) and in the Form of Note attached as Exhibit A thereto is hereby replaced with “March 31, 2013.” 
 2.2 Reduction in Committed Funds. Effective May 15, 2012 the Schedule of Committed Funds shall be amended by replacing the amounts set forth therein for each Lender as “Committed
Funds” as follows: 
  

					
	 Lender
	  	Committed Funds	 
	 Sanderling Venture Partners VI Co-Investment Fund, L.P.
	  	$	1,918,627.11	  
	 Sanderling VI Beteiligungs GmbH & Co KG
	  	$	37,131.32	  
	 Sanderling VI Limited Partnership
	  	$	44,241.58	  
	 Alafi Capital Company LLC
	  	$	1,000,000.00	  
	 Total
	  	$	3,000,000.00	  

 2.3 Warrant Coverage. In consideration of the extension of the Commitment Period under Section 1.2 and the
Maturity Date under Section 1.4 pursuant to Section 2.1 above, additional Warrants (together, the “2013 Extension Warrants”) to purchase an aggregate of 2,343,053 shares of Common Stock shall be issued to the Lenders, with
each Lender entitled to receive a pro rata number of such 2013 Extension Warrants based on the portion of the Committed Funds to be loaned by each such Lender. Such 2013 Extension Warrants shall be in the form attached as Exhibit A hereto and
shall have an Exercise Price equal to the Extension Exercise Price. 
 2.4 Payment to Company for 2013 Extension Warrants. The Lenders
shall make any required payment for the 2013 Extension Warrants under the applicable rules of The NASDAQ Global Market at the time such 2013 Extension Warrants are to be issued. If any such payment is required, each Lender may cause a fewer number
of 2013 Extension Warrants to be issued to it in lieu of making such payment upon receipt of such 2013 Extension Warrants. 
 2.5 Guaranty;
Reduction of Guaranty and Committed Funds. (a) The parties acknowledge that Sanderling Venture Partners VI Co-Investment Fund, L.P. and Alafi Capital Company LLC have each entered into a Second Amended and Restated Unconditional Limited
Guaranty, dated as of November 30, 2011, and in each case, as affirmed by the respective guarantor on the date thereof, in favor of Silicon Valley Bank, guarantying repayment of amounts set forth therein, but each having a

  
 2 

 
maximum liability of $5,000,000 of principal amount under the Amended Revolver. The parties agree that the Company may agree to extend the maturity date of the Amended Revolver to a date no later
than March 31, 2013, and that in such event, the Lenders shall each cause their respective Second Amended and Restated Unconditional Limited Guaranty agreements to be extended to such March 31, 2013 maturity date, with any adjustments
necessary to provide for the reduction in Committed Funds set forth in Section 2.2 hereof, in such form, and together with such other documents or arrangements supporting, securing or collateralizing such guaranty obligation (including, without
limitation, a letter of credit and covenants with respect to providing certain limited financial information), all as may be requested by Silicon Valley Bank in its commercially reasonable discretion; all fees payable to Silicon Valley Bank in
connection with such arrangements will be paid by the Company. 
 2.6 Registration Rights. The Company agrees to file with the SEC a
registration statement (or amend a current registration statement) with respect to the maximum number of Warrant Shares issuable upon exercise of the 2013 Extension Warrants (and any other previously unregistered Warrants) on or prior to
September 30, 2012, unless the Lenders agree to delay such registration statement. 
 ARTICLE 3 

MISCELLANEOUS 
 3.1
Agreement Conditions. This Sixth Amendment is expressly conditioned on the further extension of the maturity date of the Amended Revolver to a date no later than March 31, 2013, and the absence of material amendment to the other terms of
such Amended Revolver without the written consent of the Lenders. 
 3.2 Original Agreements in Full Force and Effect. Except as
expressly modified by this Sixth Amendment, the terms of the Existing Agreement (including without limitation the First Amendment, Second Amendment, Third Amendment, Fourth Amendment, and Fifth Amendment thereto) shall continue in full force and
effect without modification. 
 3.3 Titles and Subtitles; Construction. The titles of the Sections and Subsections of this
Sixth Amendment are for convenience of reference only and are not to be considered in construing this Sixth Amendment. All words used in this Sixth Amendment will be construed to be of such gender or number as the circumstances require. 

3.4 Counterparts. This Sixth Amendment may be executed by facsimile and in any number of counterparts, each of which shall be deemed an original,
and all of which together shall constitute one instrument. 
 3.5 Successors and Assigns. Except as otherwise expressly provided herein,
the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto. 
 3.6 Amendment and Waiver. The terms of this Sixth Amendment may be amended only through a written agreement signed by the Lenders and by the Company. Any term, representation, warranty or covenant
hereof may be waived by the party that is entitled to the benefit thereof, but no such waiver in any one or more instances shall be deemed or construed as a waiver of the same or any other term of this Sixth Amendment on any future occasion.

  
 3 

 3.7 Conflict. The Parties acknowledge that the terms of this Sixth Amendment are intended to amend
the terms of the Existing Agreement. Accordingly, in the event of a conflict between the terms of this Sixth Amendment and the Existing Agreement, the terms contained in this Sixth Amendment shall control for all purposes. 

3.9 Severability. In case any provision of this Sixth Amendment shall be invalid, illegal or unenforceable, the validity, legality and
enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 3.10 Governing Law. This Sixth
Amendment shall be governed in all respects by the internal laws of the State of Delaware, without giving effect to principles of conflicts of law. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 4 

 IN WITNESS WHEREOF, the Parties hereto have caused this Sixth Amendment to be signed by duly
authorized officers or representatives, effective as of the date first written above. 
  

			
	STEREOTAXIS, INC.
		
	By:	 	/s/ Michael P. Kaminski
	Name:	 	Michael P. Kaminski
	Title:	 	President and Chief Executive Officer
	
	SANDERLING VENTURE PARTNERS VI CO-INVESTMENT FUND, L.P.
	
	By: Middleton, McNeil, Mills & Associates VI, LLC
		
	By:	 	/s/ Fred A. Middleton
	Fred A. Middleton, Managing Director
	
	SANDERLING VI LIMITED PARTNERSHIP
	
	By: Middleton, McNeil, Mills & Associates VI, LLC
		
	By:	 	/s/ Fred A. Middleton
	Fred A. Middleton, Managing Director
	
	SANDERLING VI BETEILIGUNGS GMBH & CO. KG
	
	By: Middleton, McNeil, Mills & Associates VI, LLC
		
	By:	 	/s/ Fred A. Middleton
	Fred A. Middleton, Managing Director
	
	ALAFI CAPITAL COMPANY LLC
		
	By:	 	/s/ Christopher Alafi
		 	Christopher Alafi, Manager

  
 5 

 Exhibit 4.6 
 Exhibit A 
 Form of 2013 Extension Warrant 

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT (AS DEFINED HEREIN), OR UNDER ANY STATE SECURITIES LAWS, IN RELIANCE UPON EXEMPTIONS
FROM REGISTRATION FOR NON-PUBLIC OFFERINGS. THIS SECURITY MAY ONLY BE SOLD OR OTHERWISE TRANSFERRED TO A “PERMITTED TRANSFEREE” (AS DEFINED HEREIN) OR PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE
STATE SECURITIES LAWS OR IN A TRANSACTION EXEMPT FROM THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 
  

			
	 Issue Date: May 7, 2012
	 	Warrant
No.:                            

 STEREOTAXIS, INC. 
 COMMON STOCK PURCHASE WARRANT 
 TO PURCHASE SHARES OF

 COMMON STOCK, $0.001 PAR VALUE PER SHARE 

This is to certify that, FOR VALUE
RECEIVED,                                        
             (“Warrantholder”), is entitled to purchase, subject to the provisions of this Common Stock Purchase Warrant (“Warrant”), from Stereotaxis,
Inc., a corporation organized under the laws of Delaware (“Company”), at any time and from time to time on or after the Issue Date above, but not later than 5:00 P.M., St. Louis, Missouri time, on May 7, 2017 (the
“Expiration Date”),
[            ]1 shares (“Warrant Shares”) of Common Stock, $0.001 par value (“Common Stock”), of the Company, at an exercise price per share equal to $0.3361 (the exercise price in
effect from time to time hereafter being herein called the “Warrant Price”). The number of Warrant Shares purchasable upon exercise of this Warrant and the Warrant Price shall be subject to adjustment from time to time as described
herein. 
 This Warrant has been issued pursuant to the terms of the Note and Warrant Purchase Agreement, dated
February 21, 2008, amended by the First Amendment to Note and Warrant Purchase Agreement, made effective as of December 29, 2008, the Second Amendment to Note and Warrant Purchase Agreement, dated as of October 9, 2009, the Third
Amendment to Note and Warrant Purchase Agreement, dated as of November 10, 2010, the Fourth Amendment to Note and Warrant Purchase Agreement, dated as of March 30, 2012, the Fifth Amendment to Note and Warrant Purchase Agreement, dated as
of May 1, 2012, and by the Sixth Amendment to Note and Warrant Purchase Agreement, dated as of May 7, 2012 (as amended, the “Purchase Agreement”) by and among the Company, the Warrantholder and the other lenders set forth
therein. Capitalized terms used herein and not defined shall have the meaning specified in the Purchase Agreement. 
  

 

	1 	 For each Lender, insert (10.5)*(1/12)*(0.3*Committed Funds)/ 2013 Extension Exercise Price. 

 1. Registration. The Company shall maintain books for the transfer and registration
of the Warrant. Upon the initial issuance of the Warrant, the Company shall issue and register the Warrant in the name of the Warrantholder. 
 2. Transfers. As provided herein, this Warrant may be transferred only pursuant to a registration statement filed under the Securities Act of 1933, as amended (the “Securities
Act”), or an exemption from registration thereunder. Subject to such restrictions, the Company shall transfer this Warrant from time to time, upon the books to be maintained by the Company for that purpose, upon surrender hereof for
transfer properly endorsed or accompanied by appropriate instructions for transfer upon any such transfer, and a new Warrant shall be issued to the transferee and the surrendered Warrant shall be canceled by the Company. References to Warrantholder
or holder shall include any such transferee. 
 3. Exercise of Warrant. The Warrantholder may exercise this Warrant to
purchase the Warrant Shares, in whole or in part, at any time and from time to time on and after the Issue Date and before the Expiration Date upon surrender of the Warrant, together with delivery of the duly executed Warrant exercise form attached
hereto (the “Exercise Agreement”) (which may be by fax or portable document format (pdf) delivered by email), to the Company during normal business hours on any business day at the Company’s principal executive offices (or such
other office or agency of the Company as it may designate by notice to the holder hereof), and upon payment to the Company in cash, by certified or official bank check or by wire transfer for the account of the Company of the Warrant Price for the
Warrant Shares specified in the Exercise Agreement. The Warrant Shares so purchased shall be deemed to be issued to the holder hereof or such holder’s designee, as the record owner of such shares, as of the close of business on the date on
which the completed Exercise Agreement shall have been delivered to the Company (or such later date as may be specified in the Exercise Agreement). Certificates for the Warrant Shares so purchased, representing the aggregate number of shares
specified in the Exercise Agreement, shall be delivered to the holder hereof within a reasonable time, not exceeding five (5) business days, after this Warrant shall have been so exercised. The certificates so delivered shall be in such
denominations as may be requested by the holder hereof and shall be registered in the name of such holder or such other name as shall be designated by such holder. If this Warrant shall have been exercised only in part, then, unless this Warrant has
expired, the Company shall, at its expense, at the time of delivery of such certificates, deliver to the holder a new Warrant representing the number of shares with respect to which this Warrant shall not then have been exercised. 

4. Cashless Exercise. (a) The Warrantholder may, at its election exercised in its sole discretion, exercise this Warrant and,
in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Warrant Price for the Warrant Shares specified in the Exercise Agreement, elect instead to receive upon such exercise the
“Net Number” of shares of Common Stock determined according to the following formula (a “Cashless Exercise”): 

  
 2 

 Net Number = (A x B) - (A x C) 

B 
 For purposes of the foregoing formula: 
 A = the total number of shares with
respect to which this Warrant is then being exercised. 
 B = the Closing Price of the Common Stock on NASDAQ on the Trading Day
immediately preceding the date of the Exercise Notice. 
 C = the Warrant Price then in effect for the applicable Warrant Shares
at the time of such exercise. 
 (b) Certain Definitions. 

“Trading Day” shall mean a day on which the principal national securities exchange on which the Common Stock is listed
or admitted to trading is open for business. 
 “Closing Price” with respect to Common Stock on any day means
the reported last sales price regular way on The NASDAQ Global Select Market (“NASDAQ”), or, if no such reported sale occurs on such day, the average of the closing bid and asked prices regular way on such day, in each case as
reported in the principal consolidated transaction reporting system with respect to securities listed on the principal national securities exchange on which such class of security is listed or admitted to trading as reported by NASDAQ or any
comparable system then in use or, if not so reported, as reported by any New York Stock Exchange member firm reasonably selected by the Company for such purpose. 
 5. Compliance with the Securities Act. Neither this Warrant nor the Common Stock issued upon exercise hereof nor any other security issued or issuable upon exercise of this Warrant may be offered
or sold except as provided in this Warrant and in conformity with the Securities Act, and then only against receipt of an agreement of such person to whom such offer of sale is made to comply with the provisions of this Section 5 with respect
to any resale or other disposition of such security. The Company may cause the legend set forth on the first page of this Warrant to be set forth on each Warrant or similar legend on the Warrant Shares or any other security issued or issuable upon
exercise of this Warrant until the Warrant Shares have been registered for resale, unless counsel for the Company is of the opinion as to any such security that such legend is unnecessary. 

6. Payment of Taxes. The Company will pay any documentary stamp taxes attributable to the initial issuance of Warrant Shares
issuable upon the exercise of the Warrant; provided, however, that the Company shall not be required to pay any tax or taxes which may be payable in respect of any transfer involved in the issuance or delivery of any certificates for Warrant Shares
in a name other than that of the registered holder of this Warrant in respect of which such shares are issued. The holder shall be responsible for income taxes due under federal or state law, if any such tax is due. 

  
 3 

 7. Mutilated or Missing Warrants. In case this Warrant shall be mutilated, lost,
stolen, or destroyed, the Company shall issue in exchange and substitution of and upon cancellation of the mutilated Warrant, or in lieu of and substitution for the Warrant lost, stolen or destroyed, a new Warrant of like tenor and for the purchase
of a like number of Warrant Shares, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction of the Warrant, and with respect to a lost, stolen or destroyed Warrant, reasonable indemnity or bond
with respect thereto, if reasonably requested by the Company. 
 8. Insufficient Authorized Shares. If at any time while
this Warrant remains outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve for issuance upon exercise of this Warrant at least a number of shares of Common
Stock equal to (the “Required Reserve Amount”) the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of all of this Warrant then outstanding (an “Authorized Share
Failure”), then the Company shall, within 90 days after the occurrence of such Authorized Share Failure take action to increase the Company’s authorized and unissued shares of Common Stock to an amount sufficient to allow the Company
to reserve the Required Reserve Amount for this Warrant then outstanding. The Company shall not be in breach of its obligation to reserve the Required Reserve Amount during such period so long as it is taking good faith efforts to satisfy its
obligations under this covenant. 
 9. Warrant Price. The Warrant Price, subject to adjustment as provided in
Section 10 hereof, shall, if payment is made in cash or by certified check, be payable in lawful money of the United States of America. 
 10. Adjustment of Warrant Exercise Price and Number of Shares. If the Company at any time after the date of issuance of this Warrant subdivides (by any stock split, stock dividend, recapitalization
or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Warrant Price in effect immediately prior to such subdivision will be proportionately reduced and the number of shares of Common Stock
obtainable upon exercise of this Warrant will be proportionately increased. If the Company at any time after the date of issuance of this Warrant combines (by combination, reverse stock split or otherwise) one or more classes of its outstanding
shares of Common Stock into a smaller number of shares, the Warrant Price in effect immediately prior to such combination will be proportionately increased and the number of shares of Common Stock obtainable upon exercise of this Warrant will be
proportionately decreased. Any adjustment under this Section 10 shall become effective at the close of business on the date the subdivision or combination becomes effective. 

11. Replacement Warrants. The Company agrees that after any request from time to time of the Warrantholder and within ten
(10) business days upon the Company’s receipt of this Warrant, the Company shall deliver to such holder a new Warrant in substitution of this Warrant which is identical in all respects except that the then Warrant Price shall be
appropriately specified in the Warrant, and the Warrant shall specify the fixed number of Warrant Shares into which this Warrant is then exercisable. Such changes are intended not as amendments to the Warrant but only as clarification of the
adjustment in the preceding Section for convenience purposes, and such adjustments shall not affect any provisions concerning adjustments to the Warrant Price or number of Warrant Shares contained herein. 

  
 4 

 12. Fractional Interest. The Company shall not be required to issue fractions of
Warrant Shares upon the exercise of the Warrant. If any fraction of a Warrant Share would, except for the provisions of this Section, be issuable upon the exercise of the Warrant (or specified portions thereof), the Company shall round such
calculation to the nearest whole number and disregard the fraction. 
 13. Benefits. Nothing in this Warrant shall be
construed to give any person, firm or corporation (other than the Company and the Warrantholder) any legal or equitable right, remedy or claim, it being agreed that this Warrant shall be for the sole and exclusive benefit of the Company and the
Warrantholder. 
 14. Notices to Warrantholder. Upon the happening of any event requiring an adjustment of the Warrant
Price, the Company shall forthwith give written notice thereof to the Warrantholder at the address appearing in the records of the Company, stating the adjusted Warrant Price and the adjusted number of Warrant Shares resulting from such event and
setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. In the event of a dispute with respect to any such calculation, the certificate of the Company’s independent certified public
accountants shall be conclusive evidence of the correctness of any computation made, absent manifest error. Failure to give such notice to the Warrantholder or any defect therein shall not affect the legality or validity of the subject adjustment.

 15. Identity of Transfer Agent. The Transfer Agent for the Common Stock is Broadridge. Forthwith upon the appointment
of any subsequent transfer agent for the Common Stock or other shares of the Company’s capital stock issuable upon the exercise of the rights of purchase represented by the Warrant, the Company will fax to the Warrantholder a statement setting
forth the name and address of such transfer agent. 
 16. Notices. Any notice pursuant hereto to be given or made by the
Warrantholder to or on the Company shall be sufficiently given or made if delivered personally or by facsimile or if sent by an internationally recognized courier, addressed as follows: 

Stereotaxis, Inc. 
 4320 Forest Park Avenue, Suite 100 
 St. Louis, Missouri 63108

 Fax: (314) 678-6110 

Attention: Chief Financial Officer 
 or such other address as the Company may specify in writing by notice to the Warrantholder complying as to delivery with the terms of this Section 16. 

Any notice pursuant hereto to be given or made by the Company to or on the Warrantholder shall be sufficiently given or made if personally delivered, if
sent by facsimile or if sent by an internationally recognized courier service by overnight or two-day service, to the address set 

  
 5 

 
forth on the books of the Company or, as to each of the Company and the Warrantholder, at such other address as shall be designated by such party by written notice to the other party complying as
to delivery with the terms of this Section 16. 
 All such notices, requests, demands, directions and other communications shall, when sent
by courier, be effective two (2) days after delivery to such courier as provided and addressed as aforesaid. All faxes shall be effective upon receipt. 
 17. Registration Rights. The holder of this Warrant is entitled to the benefit of certain registration rights in respect of the Warrant Shares as provided in the Purchase Agreement. 

18. Successors. Subject to the restrictions on transfer described in Section 21 below, all the covenants and provisions
hereof by or for the benefit of the Warrantholder shall bind and inure to the benefit of its respective successors and assigns hereunder. 
 19. Governing Law. This Warrant shall be deemed to be a contract made under the laws of the State of Delaware, without giving effect to its conflict of law principles, and for all purposes shall be
construed in accordance with the laws of said State. 
 20. Absolute Obligation to Issue Warrant Shares. The
Company’s obligations to issue and deliver Warrant Shares in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by the holder hereof to enforce the same, any waiver or consent with respect to
any provision hereof, the recovery of any judgment against any person or entity or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the holder hereof or any other
Person of any obligation to the Company or any violation or alleged violation of law by the holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation of the Company to the holder hereof in
connection with the issuance of Warrant Shares. The Company will at no time close its shareholder books or records in any manner which interferes with the timely exercise of this Warrant. 

21. Assignment, etc. The Warrantholder agrees that in no event will it make a transfer or disposition of any of this Warrant or
the Warrant Shares (other than pursuant to an effective registration statement under the Securities Act), unless and until (i) it shall have notified the Company of the proposed disposition and shall have furnished the Company with a statement
of the circumstances surrounding the disposition and assurance that the proposed disposition is in compliance with all applicable laws, and (ii) if reasonably requested by the Company, at the expense of such Warrantholder or its transferee, it
shall have furnished to the Company an opinion of counsel, reasonably satisfactory to the Company, to the effect that such transfer may be made without registration under the Securities Act. Notwithstanding the foregoing, no formal notice or opinion
of counsel shall be required for the transfer by an Warrantholder to any of the following (each, a “Permitted Transferee”): (x) any partner of a Warrantholder or to a retired partner of a Warrantholder, who retires after the
date of this Warrant, (y) the estate of any such partner or a retired partner or for the transfer by gift, will or intestate succession of any partner to his spouse or lineal descendants or ancestors or (z) any

  
 6 

 
entity which is a wholly-owned subsidiary of the Warrantholder or which is under common control with the Warrantholder; provided, however, in all cases where no legal opinion is required that the
transferee shall agree in writing to be subject to the terms of this Warrant to the same extent as if it were the original Warrantholder hereunder. 
 IN WITNESS WHEREOF, the Company has caused this Common Stock Purchase Warrant to be duly executed as of the date first written above. 

 

			
	STEREOTAXIS, INC.
		
	By:	 	 
	Name:
	Title:

  
 7 

 STEREOTAXIS, INC. 

WARRANT EXERCISE FORM 

Stereotaxis, Inc. 
 4320 Forest Park Avenue,
Suite 100 
 St. Louis, Missouri 63108 

Fax: (314) 678-6110 
 Attention: Chief
Financial Officer 
 This undersigned hereby irrevocably elects to exercise the right of purchase represented by the Common Stock Purchase
Warrant (“Warrant”) for, and to purchase thereunder             shares of Common Stock (“Warrant Shares”) provided for therein, and requests that
certificates for the Warrant Shares be issued as follows: 
  

					
	 Name:
	 	 	 	
	 Address:
	 	 	 	
		 	 	 	
		 	 	 	

 and, if the number of Warrant Shares shall not be all the Warrant Shares purchasable upon exercise of the Warrant, that a
new Warrant for the balance of the Warrant Shares. 
  

					
	 Dated:
	 	 	 	
			
	 Signature:
	 	 	 	
			
	 Print Name:
	 	 	 	

  

					
	 Address:
	 	 	 	
		 	 	 	
		 	 	 	

  
 8Form of Restricted Stock Award Agreement

 Exhibit 10.1 
 RESTRICTED STOCK AGREEMENT 
 UNDER THE IBERIABANK CORPORATION

 2010 STOCK INCENTIVE PLAN 
 THIS INCENTIVE AGREEMENT (“Agreement”) is entered into as of,                     
between IBERIABANK Corporation (“IBKC” or (the “Company”) and                     (the “Award Recipient”).

 WHEREAS, under the 2010 Stock Incentive Plan (the “Plan”), the Compensation Committee of the IBKC Board of
Directors (the “Committee”) may, among other things, award shares of common stock of IBKC (the “Common Stock”) in the form of restricted stock (“Restricted Stock”) to a key employee or Director of IBKC or one of its
subsidiaries (collectively, the “Company”); 
 NOW, THEREFORE, in consideration of the premises, it is agreed as
follows: 
 1. Conditional Award of Restricted Stock 

Pursuant to the terms of the Plan, the Award Recipient is hereby awarded, subject to the other terms, conditions, and restrictions
contained herein,                     shares of Restricted Stock. 
 2. Award Restrictions 
 2.1 The shares of Restricted Stock and the right to
vote them and to receive dividends thereon may not be sold, assigned, transferred, exchanged, pledged, hypothecated or otherwise encumbered until such time as the shares vest and the restrictions imposed thereon lapse, as provided below. 

2.2 The shares of Restricted Stock issued to the Award Recipient shall become vested and nonforfeitable and the restrictions imposed
thereon will lapse as to one third (33 1/3%) of the shares of Restricted Stock on each of the first through third anniversaries of the date of this Agreement; provided that on each vesting date if a fraction of a share would vest, a whole share
shall vest in lieu thereof and on the last date the number of shares that vest will be the total number of shares awarded less the total number of shares previously vested; and provided further that on the applicable vesting date the Award Recipient
is in the employ of or serving as a member of the Board of IBKC. The period during which the restrictions imposed on the shares of Restricted Stock by the Plan and this Agreement are in effect is referred to herein as the “Restricted
Period.” During the Restricted Period, the Award Recipient shall be entitled to all rights of a shareholder of IBKC, including the right to vote such shares of Restricted Stock and to receive dividends thereon. 

  
 -1-

 2.3 All restrictions on the Restricted Stock issued to the Award Recipient shall immediately
lapse and the shares shall vest (a) if the Award Recipient dies while he is employed by or serving on the Board of the Company, (b) if the Award Recipient’s Continuous Service to the Company terminates as a result of Disability, or
(c) if service on the Board terminates due to ineligibility for re-election to serve on the Board because of having reached the mandatory retirement age. Unless otherwise determined by the Committee, the Award Recipient shall forfeit his or her
unvested Restricted Stock upon the termination of his or her Continuous Service to the Company, for any reason, other than as provided in the foregoing sentence. 
 3. Registration of Stock Ownership 
 3.1 The shares of Restricted Stock
shall be registered in the name of the Award Recipient by book entry. A stock power endorsed in blank by the Award Recipient, substantially in the form attached hereto as Exhibit A, shall be deposited with IBKC. The restrictions on transfer and
forfeiture terms of the Restricted Stock under the Plan and the Agreement shall be reflected in the books of IBKC’s transfer agent and noted on the written information statement required to be provided to the Award Recipient under Louisiana
law. 
 3.2 Upon the lapse of restrictions on any shares of Restricted Stock issued to the Award Recipient, IBKC shall cause a
stock certificate without any restrictive legend representing such shares of Restricted Stock to be issued in the name of the Award Recipient or his nominee within 30 days after the end of the Restricted Period. Upon receipt of such stock
certificate, the Award Recipient is free to hold or dispose of the shares of Common Stock represented by such certificate subject to applicable securities laws. 
 4. Dividends 
 Any dividends paid on the shares of Restricted Stock granted
to the Award Recipient shall be paid to the Award Recipient as soon as practicable following the date such dividends are declared and paid to the Company’s shareholders. 
 5. Withholding Taxes 
 5.1 IBKC shall have the right to withhold from any
payments or stock issuances under the Plan, or to collect as a condition of payment, any taxes required by law to be withheld. By signing this Award Agreement, the Award Participant agrees that he or she is solely responsible for the satisfaction of
any taxes that may arise (including taxes arising under Sections 409A or 4999 of the Code) and that IBKC shall not have any obligation whatsoever to pay such taxes. 
 5.2 Unless an Award Recipient timely makes the election described in Section 5.3, at the time that all or any portion of the Restricted Stock vests the Award Recipient must deliver to IBKC the amount
of income tax withholding required by law. In accordance with the terms of the Plan, the Award Recipient may satisfy the tax withholding obligation by electing (the “Election”) to have IBKC withhold from the Shares the Award Recipient
otherwise would 

  
 -2-

 
receive Shares of Common Stock having a value equal to the minimum amount required to be withheld. The value of the shares to be withheld shall be based on the Fair Market Value of the Common
Stock on the date that the amount of tax to be withheld shall be determined (the “Tax Date”). Each Election must be made prior to the Tax Date. The Committee may disapprove of any Election, may suspend or terminate the right to make
Elections, or may provide with respect to any Restricted Stock that the right to make Elections shall not apply to such Restricted Stock, except that if the Award Recipient is an Executive Officer or is otherwise subject to Section 16 of the
Securities Exchange Act of 1934, the Award Recipient’s right to handle the payment of withholding taxes may not be revoked by the Committee. 
 5.3 The Award Recipient understands that the Award Recipient (and not the Company) shall be responsible for the Award Recipient’s own tax liability that may arise as a result of the transactions
contemplated by this Agreement. The Award Recipient understands that Section 83 of the Internal Revenue Code of 1986, as amended (the “Code”), taxes as ordinary income the Fair Market Value of the Restricted Stock as of the date any
restrictions on the shares lapse. The Award Recipient understands that the Award Recipient may elect to be taxed at the time the Restricted Stock is granted rather than upon vesting by filing an election under Section 83(b) of the Code with the
I.R.S. within thirty days from the date of grant. The form for making this election is available from the Secretary of IBKC upon the request of the Award Recipient. 
 6. Additional Conditions 
 Anything in this Agreement to the contrary
notwithstanding, if at any time IBKC further determines, in its sole discretion, that the listing, registration or qualification (or any updating of any document) of the shares of Common Stock issued or issuable pursuant hereto is necessary on any
securities exchange or under any federal or state securities or blue sky law, or that the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with, the issuance of shares of Common
Stock pursuant hereto, or the removal or any restrictions imposed on such shares, such shares of Common Stock shall not be issued, in whole or in part, or the restrictions thereon removed, unless such listing, registration, qualification, consent or
approval shall have been effected or obtained free of any conditions not acceptable to IBKC. 
 7. No Contract of Employment
Intended 
 Nothing in this Agreement shall confer upon the Award Recipient any right to continue in the employment of the
Company or to interfere in any way with the right of the Company to terminate the Award Recipient’s employment relationship with the Company at any time. 
 8. Binding Effect 
 This Agreement shall inure to the benefit of and be
binding upon the parties hereto and their respective heirs, executors, administrators and successors. 

  
 -3-

 9. Inconsistent Provisions 

The shares of Restricted Stock covered hereby are subject to the provisions of the Plan. If any provision of this Agreement conflicts
with a provision of the Plan, the Plan provision shall control. 
 10. Designation of Beneficiary 

The Award Recipient may expressly designate a beneficiary to his or her interest (the “Beneficiary”), if any, to this Agreement
by completing and executing a designation of beneficiary agreement substantially in the form attached to this Agreement as Exhibit B (the “Designation of Beneficiary”) and delivering an executed copy of the Designation of
Beneficiary to IBKC. 
 11. Notices 
 Any notice or communication required or permitted by any provision of this Agreement to be given to the Award Recipient shall be in writing and shall be delivered personally or sent by certified mail,
return receipt requested, addressed to the Award Recipient at the last address that the Company had for the Award Recipient on its records. Each party may, from time to time, by notice to the other party hereto, specify a new address for delivery of
notices relating to this Agreement. Any such notice shall be deemed to be given as of the date such notice is personally delivered or properly mailed. 
 12. Modifications 
 This Agreement may be modified or amended at any time,
provided that Award Recipient must consent in writing to any modification that adversely alters or impairs any rights or obligations under this Agreement. 
 13. Headings 
 Section and other headings contained in this Agreement are
for reference purposes only and are not intended to describe, interpret, define or limit the scope or intent of this Agreement or any provision hereof. 
 14. Severability 
 Every provision of this Agreement and of the Plan is
intended to be severable. If any term hereof is illegal or invalid for any reason, such illegality or invalidity shall not affect the validity or legality of the remaining terms of this Award Agreement. 

15. Governing Law 
 The laws of the State of Louisiana shall govern the validity of this Agreement, the construction of its terms, and the interpretation of the rights and duties of the parties hereto. 

  
 -4-

 16. Counterparts 

This Agreement may be executed by the parties hereto in separate counterparts, each of which when so executed and delivered shall be an
original, but all such counterparts shall together constitute one and the same instrument. 
 17. Restrictions on Transfer

 This Agreement may not be sold, pledged, or otherwise transferred without the prior written consent of the Committee.
Notwithstanding the foregoing, the Award Recipient may transfer this Agreement (i) by instrument to an inter vivos or testamentary trust (or other entity) in which each beneficiary is a permissible gift recipient, as such is set forth in
subsection (ii) of this Section 17, or (ii) by gift to charitable institutions or by gift or transfer for consideration to any of the following relatives of the Award Recipient (or to an inter vivos trust, testamentary trust or other
entity primarily for the benefit of the following relatives of the Participant): any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, domestic partner, sibling, niece, nephew, mother-in-law, father-in-law,
son-in-law, daughter-in-law, brother-in-law, or sister-in-law, and shall include adoptive relationships. Any transferee of the Award Recipient’s rights shall succeed and be subject to all of the terms of this Agreement and the Plan.

 [Signature Page Follows] 

  
 -5-

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as
of the day and year first above written. 
  

			
	IBERIABANK CORPORATION
		
	By:	 	  

		 	A duly designated representative of the Company
		
		 	  

		 	Award Recipient

  

			
	Attest:	 	

  
 -6-

 STOCK POWER 
 PURSUANT TO 
 IBERIABANK CORPORATION 

2010 STOCK INCENTIVE PLAN 
  

					
	State of	 	  
	  	)
		 		  	)             SSN:
	Parish of	 	  
	  	)

 Know all men by these presents that I,
                                         (name of
Award Recipient), do hereby make, constitute and appoint the members of the Compensation Committee of the IBERIABANK Corporation Board of Directors, or any of the them, as appointed by such Board of Directors from time to time, for my benefit as the
recipient of an award under the 2010 Stock Incentive Plan (as evidenced by the attached Agreement dated as of             , 20    , which is incorporated herein by
reference), and in my name, place and stead, my true and lawful attorney-in-fact: 
 To retain the stock certificates or other
evidence of ownership of the Restricted Stock issued to me pursuant to such Agreement until the termination of the applicable Restricted Period and the lapse of restrictions under the terms of such Agreement and, for that purpose, to make, execute
and deliver all assignments or other instruments of transfer deemed necessary or appropriate, to give a receipt or receipts for the same and generally to do all lawful acts necessary or appropriate to secure for me the Restricted Stock issued under
such Agreement. 
  

							
	Dated:	 	  
	 		 	  

		 		 		 	Signature of Award Recipient

 IBERIABANK CORPORATION 

 
  

Designation of Beneficiary 
  

 
 In the event of
my death or “Disability” within the meaning of the IBERIABANK Corporation 2010 Stock Incentive Plan (the “Plan”), I hereby designate the following person to be my beneficiary for the Award(s) (within the
meaning of the Plan) identified below: 
  

			
	Name of Beneficiary:	  	  

		
	Address:	  	  

		
		  	  

		
		  	  

		
	Social Security No.:	  	  

 This beneficiary designation of mine relates to any and all of my rights under the following Award or
Awards: 
  

	 	 ̈	the
                                         Award
that I received pursuant to an award agreement dated                  ,          between me and IBERIABANK Corporation (the
“Company”). 

 I understand that this beneficiary designation operates to entitle
the above-named beneficiary to succeed, in the event of my death, to any and all of my rights under the Award(s) designated above, and shall be effective from the date this form is delivered to the Company until such date as I revoke this
designation. A revocation shall occur only if I deliver to an executive officer of the Company either (i) a written revocation of this designation that is signed by me and notarized, or (ii) a designation of death beneficiary, in the form
set forth herein, that is executed and notarized on a later date. 
  

					
		  	Date:	 	  

			
		  	Your Signature:	 	  

			
		  	Your Name (printed):

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}]]